Return On Assets in % of Mineralys Therapeutics, Inc. from Q3 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Mineralys Therapeutics, Inc. quarterly/annual Return On Assets history and change rate from Q3 2023 to Q3 2025.
  • Mineralys Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -45.8 %, a 11.4% increase year-over-year.
  • Mineralys Therapeutics, Inc. annual Return On Assets for 2024 was -62.4 %, a 144% decline from 2023.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Mineralys Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -45.8 +5.9 +11.4% 01 Jul 2025 30 Sep 2025
Q2 2025 -65.5 -25.5 -63.5% 01 Apr 2025 30 Jun 2025
Q1 2025 -65.7 -34.6 -111% 01 Jan 2025 31 Mar 2025
Q4 2024 -62.4 -36.9 -144% 01 Oct 2024 31 Dec 2024
Q3 2024 -51.7 -28.8 -126% 01 Jul 2024 30 Sep 2024
Q2 2024 -40.1 01 Apr 2024 30 Jun 2024
Q1 2024 -31.1 01 Jan 2024 31 Mar 2024
Q4 2023 -25.5 01 Oct 2023 31 Dec 2023
Q3 2023 -22.9 01 Jul 2023 30 Sep 2023

Mineralys Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -62.4 -36.9 -144% 01 Jan 2024 31 Dec 2024
2023 -25.5 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.